Venous thromboembolism incidence and risk factors associated with immune checkpoint inhibitors among patients with advanced non-small cell lung cancer

BACKGROUND: Venous thromboembolism (VTE) is a significant cause of morbidity and mortality in patients with lung cancer. Systemic therapies, such as chemotherapy (chemo), are associated with increased risk of VTE. Immune checkpoint inhibitors (ICIs) are a new standard of care for the treatment of lu...

Descripción completa

Detalles Bibliográficos
Autores principales: Khorana, Alok A, Palaia, Jennell, Rosenblatt, Lisa, Pisupati, Radhika, Huang, Ning, Nguyen, Chi, Barron, John, Gallagher, Kerrin, Bond, T Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9853260/
https://www.ncbi.nlm.nih.gov/pubmed/36657815
http://dx.doi.org/10.1136/jitc-2022-006072